Reversal of antibiotic resistance in Gram-positive bacteria by the antihistaminic azelastine

APMIS

Volumn 120, Issue 3, 2012, Pages 215-220

  El Nakeeb, Moustafa A ^a   Abou Shleib, Hamida M ^a   Khalil, Amal M ^a   Omar, Hoda G ^a   El Halfawy, Omar M ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Antibiotic resistance; Antihistaminic; Azelastine; Gram positive bacteria; Multi drug resistant bacteria

Indexed keywords

AMPICILLIN; AZELASTINE; CEFEPIME; CEFOTAXIME; CEFRADINE; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG POTENTIATION; ENTEROCOCCUS FAECIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERMEABILITY; PH; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-ALLERGIC AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PHTHALAZINES;

EID: 84857112567     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2011.02823.x     Document Type: Article

References (10)

1. World Health Organization. World health statistics 2008. Geneva: WHO Press 2008.
2. Kristiansen JE, Amaral L. The potential management of resistant infections with non-antibiotics. J Antimicrob Chemother 1997;40:319-27.
3. Kristiansen JE, Hendricks O, Delvin T, Butterworth TS, Aagaard L, Christensen JB, et al. Reversal of resistance in microorganisms by help of non-antibiotics. J Antimicrob Chemother 2007;59:1271-9.
4. Martins M, Dastidar SG, Fanning S, Kristiansen JE, Molnar J, Pages JM, et al. Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities. Int J Antimicrob Agents 2008;31:198-208.
5. El-Nakeeb MA, Abou-Shleib HM, Khalil AM, Omar HG, El-Halfawy OM. In vitro antibacterial activity of some antihistaminics belonging to different groups against multi-drug resistant clinical isolates. Braz J Microbiol 2011;42.
6. El-Nakeeb MA, Abou-Shleib HM, Khalil AM, Omar HG, El-Halfawy OM. Membrane permeability alteration of some bacterial clinical isolates by selected antihistaminics. Braz J Microbiol 2011;42.
7. Andrews JM. BSAC standardized disc susceptibility testing method (version 6). J Antimicrob Chemother 2007;60:20-41.
8. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001;48(Suppl 1):5-16.
9. England RJ, Homer JJ, Knight LC, Ell SR. Nasal pH measurement: a reliable and repeatable parameter. Clin Otolaryngol Allied Sci 1999;24:67-8.
10. Molnar J, Batho N, Csik V, Chevalier J, Cremieux A. Interaction between tricyclic psychopharmacons and some antibiotics. Acta Microbiol Immunol Hung 1995;42:277-85.